Tag: David Armstrong

Sackler Embraced Plan to Conceal OxyContin’s Strength From Doctors, Sealed Testimony Shows

February 22, 2019February 23, 2019Big Pharma

By David Armstrong As OxyContin addiction spurred a national nightmare, a member of the family that has reaped billions of dollars from the painkiller boasted that sales exceeded his “fondest dreams,” according to a secret court document obtained by ProPublica. This story is a collaboration…

OxyContin Maker Explored Expansion Into “Attractive” Anti-Addiction Market

January 30, 2019Big Pharma

By David Armstrong Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid. This story was co-published with STAT. Not content…